How does the supply of medications for clinical research work?

When we think about clinical research, the focus is usually on patients, researchers, and scientific advances. But there is an essential step behind the scenes that often goes unnoticed: the supply of medications for clinical research.

More than just a simple delivery, this process requires planning, traceability, regulatory compliance, and operational precision to ensure that the right medications are available at the right location, at the right time, and in accordance with each study protocol.

In a highly regulated and time-sensitive industry, any failure can disrupt timelines, jeopardize study phases, and create significant operational challenges.

But how does this process actually work in practice?

What is the supply of medications for clinical research?

The supply of medications for clinical research refers to the set of processes responsible for ensuring the availability of medications used in clinical trials, from procurement through delivery to research centers.

This process may involve, for example:

• sourcing and procurement of medications;
• import and export;
• proper storage;
• inventory control;
• specialized transportation;
• traceability and regulatory documentation.

Depending on the protocol, medications may include comparator products, reference drugs, placebos, or investigational therapies, each with specific handling and storage requirements.

According to the ANVISA, clinical trials involving drugs require strict compliance with regulatory standards to ensure the safety, quality, and integrity of the research data.

Why does this process require so much control?

In clinical research, each study follows a detailed protocol that specifies exactly how medications should be stored, transported, and administered.

This means that even small variations can compromise the integrity of the study.

Factors such as:

• inappropriate temperature;
• logistical delay;
• traceability issues;
• documentary inconsistencies;
• improper storage;

may directly impact the operational continuity of the research.

However, medications used in clinical trials have specific storage requirements, including temperature control and continuous monitoring of the cold chain (cold chain).

In addition, different countries may have different regulatory requirements, making logistics planning even more complex in multicenter studies.

What are the steps involved in supplying medications for clinical research?

Although the workflow may vary depending on the study, the process typically involves a few main steps.

1. Sourcing and Procurement

It all begins with identifying and procuring the medications needed for the clinical protocol.

Depending on the study, this may include domestically produced drugs, imported drugs, comparators, or specific products required by the study sponsor.

2. Importation and Regulatory Documentation

In international studies, it is common to need to import medications.

In this context, regulatory requirements, technical documentation, and the necessary authorizations come into play to ensure the process’s compliance.

3. Qualified storage

Upon receipt, medications must be stored under appropriate conditions in terms of temperature, security, and monitoring.

This step is essential for maintaining the stability and integrity of the products.

4. Specialized transportation

Distribution to research centers requires traceability and, in many cases, temperature-controlled logistics.

The predictability of the operation is essential to avoid delays that could affect the study’s timeline.

5. Delivery to the research center

Finally, the medications arrive at the research centers, where they will be used in accordance with the requirements of the clinical protocol.

The entire process must maintain adequate documentation and strict controls to ensure operational safety and regulatory compliance.

What are the main challenges facing the industry?

The supply of medications for clinical research involves challenges that go beyond traditional logistics.

Among the main ones are:

• critical deadlines;
• availability of medications;
• temperature control;
• regulatory requirements;
• traceability;
• document management;
• coordination among different stakeholders.

Since many studies have strict timelines, delays or inconsistencies can have a significant impact on the progress of the research.

As a result, predictability and planning have become increasingly strategic factors for the industry.

Why is this process so important for clinical trials?

Clinical research depends on accuracy.

Therefore, far beyond simply moving products, the supply of medications ensures that researchers have access to exactly what the protocol requires, under the right conditions and at the right time.

However, in a context of increasing regulatory complexity and advances in medical research, the efficiency of this supply chain is becoming increasingly important for supporting innovation, safety, and the continuity of clinical trials.

Sources

FDA – Clinical Trials and Protection of Human Subjects
DHL Life Sciences & Healthcare – Clinical Trials Logistics
IQVIA – Clinical Trial Supply Services